Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review

Lung cancer is the leading cause of cancer-related mortality worldwide, with five-year survival rates varying from 3–62%. Screening aims at early detection, but half of the patients are diagnosed in advanced stages, limiting therapeutic possibilities. Positron emission tomography-computed tomography...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariën, Hanne, Derveaux, Elien, Vanhove, Karolien, Adriaensens, Peter, Thomeer, Michiel, Mesotten, Liesbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229104/
https://www.ncbi.nlm.nih.gov/pubmed/35736478
http://dx.doi.org/10.3390/metabo12060545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229104/
https://www.ncbi.nlm.nih.gov/pubmed/35736478
http://dx.doi.org/10.3390/metabo12060545

Ejemplares similares